JAK2 V617F Mutation, Quantitative Test in Cape Girardeau, Missouri
The JAK2 V617F Mutation, Quantitative test contains 1 test with 2 biomarkers.
JAK2 V617F Mutation, Quantitative
Detection of JAK2 mutation is important for diagnosis and monitoring of chronic myeloproliferative neoplasms. This cell-based pyrosequencing assay determines the percentage of mutated allele compared to unmutated allele, down to 1% sensitivity and is available for use on blood, bone marrow or formalin-fixed paraffin-embedded tissue blocks, including bone marrow biopsies.